Americafirst Capital Management’s Edwards Lifesciences EW Stock Holding History

Americafirst Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-93,498	Closed	-$2.46M	–	187
2015 Q4	$2.46M	Buy	93,498 +5,484	+6%	+$142K	1.5%	22
2015 Q3	$2.09M	Buy	88,014 +12,384	+16%	+$299K	1.23%	12
2015 Q2	$1.8M	Sell	75,630 -18,678	-20%	-$422K	0.97%	27
2015 Q1	$2.24M	Buy	94,308 +91,998	+3,983%	+$2.06M	1.11%	23
2014 Q4	$49K	Sell	2,310 -169,866	-99%	-$3.41M	0.02%	226
2014 Q3	$2.93M	Buy	+172,176	New	+$2.72M	1.44%	11

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Americafirst Capital Management's EW Position: Q1 2016 in Review

Americafirst Capital Management sold out of Edwards Lifesciences (EW) in Q1 2016, closing a stake of 93,498 shares — an estimated $2.46M sold.

Americafirst Capital Management first reported a position in EW in Q3 2014 and held it in 6 quarters. The position peaked at $2.93M in Q3 2014. 659 funds tracked by Wall St. Rank hold EW as of Q1 2016.

Americafirst Capital Management reported no remaining Edwards Lifesciences position as of Q1 2016 after selling out during the quarter.
Americafirst Capital Management sold 93,498 Edwards Lifesciences shares in Q1 2016, an estimated $2.46M.
Americafirst Capital Management first reported a position in Edwards Lifesciences in Q3 2014 and held it in 6 quarters.
Americafirst Capital Management's Edwards Lifesciences position peaked at $2.93M in Q3 2014.
659 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2016.

Based on Americafirst Capital Management's 13F filing for Q1 2016, filed 16 May 2016.